Boston Medical Group review

Two things here are better than average and one is worse, and they are worth separating. Better: this is one of very few sellers that will tell a reader what the wider market costs, quoting the brand-name products in the thousands per month and non-brand programs at a few hundred. That gives someone a frame of reference instead of only a sales figure, and most of this category would rather you had no frame at all. Better again: treatment is described in named phases with doses stated in milligrams per week, so a reader can see an initiation dose set against a maintenance one — genuinely useful detail, and rarer here than it ought to be. Worse: the headline price does not survive its own footnote. The site advertises starting from a monthly figure, and the asterisk attached prices a complete twelve-week program at a total working out roughly a third higher per month, because a telemedicine platform fee sits on top of the medication line. None of that is concealed — it is written on the same page — but it is written in the footnote while the headline carries the smaller number, and the headline is what a reader remembers.

Vs median

Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Confirm any separate fee

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

Boston Medical Group does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. Confirm whether clinician visits cost extra.

Two things here are better than average and one is worse. Better: this is one of very few sellers that will tell a reader what the wider market costs, quoting brand-name products at a thousand to four thousand dollars a month and non-brand programs at a few hundred, which gives someone a frame of reference rather than only a sales figure. Better again: it describes treatment in phases and states doses in milligrams per week, so a reader can see what an initiation dose is against a maintenance one — genuinely useful, and rarer than it should be. Worse: the headline price does not survive its own footnote. The site advertises starting from a figure per month, and the asterisk attached to it prices a complete twelve-week program at a total that works out closer to a third more per month, because a telemedicine platform fee sits on top of the medication line. Nothing about that is hidden — it is written down, on the same page — but it is written in the footnote and not in the headline, and the headline is the number a reader carries away.

The advertised monthly figure excludes a platform fee that its own footnote adds back.

• The twelve-week total works out well above the headline rate per month.
• No compounding pharmacy is named.

Boston Medical Group is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Titrating up from a microdose
• The true annual cost of a plan
• Titration planner